Can Slow Breathing Reduce Alzheimer's Risk? A 2023 USC Study

Quick answer

A 2023 USC study found that four weeks of slow, paced breathing (about five seconds in, five seconds out, twice daily) lowered blood levels of amyloid-beta 40 and 42, peptides linked to Alzheimer's risk, in both younger and older adults. That's a real, measured result, but it's a blood biomarker change over a month, not proof that the exercise prevents Alzheimer's itself. The honest read is a promising early signal, not a settled finding.

Want to try this yourself? Open the Breathe page.

The claim going around is usually some version of "a breathing exercise can reduce Alzheimer's risk," which is a bigger statement than the actual research supports. The real study, led by researchers at USC's Leonard Davis School of Gerontology, is more specific and, if anything, more interesting for exactly how specific it is.

What the study actually did

108 volunteers were split into two age groups, younger adults aged 18 to 30 and older adults aged 55 to 80, and then further split by intervention. One group practiced slow, paced breathing twice a day for 20 minutes, following a visual pacer set to roughly five seconds per inhale and five seconds per exhale, about six breaths a minute, while monitoring their own heart rate variability. A control group instead tried to keep their heart rate steady through meditation and calm visualization, without the paced breathing component. Everyone kept this up for four weeks, with blood drawn before and after.

What actually changed

The slow-breathing group showed reduced plasma levels of amyloid-beta 40 and 42 compared to before the intervention. These are the peptides that, over years, can aggregate into the plaques found in Alzheimer's-affected brains, and higher circulating levels in blood are associated with greater future risk in otherwise healthy people. The meditation-and-visualization control group didn't show the same shift, which is what makes the paced-breathing detail feel like more than a coincidence.

Where the claim gets oversold

A drop in a blood biomarker over four weeks is not the same as a demonstrated reduction in Alzheimer's cases, and no study could show that on this timeline anyway, the disease develops over decades. What this research shows is that a simple, low-cost behavior visibly moved a biomarker connected to risk, in a controlled comparison against an active control group. That's a genuinely useful early finding. It's also one study, not yet independently repeated elsewhere, which is usually the point where a promising result either holds up or quietly doesn't.

The pace itself isn't anything new

Five seconds in, five seconds out works out to roughly six breaths a minute, a pace that's been studied for years under names like "resonance breathing" or "coherent breathing", mostly for its effect on heart rate variability and general stress. It's noticeably slower and more even than something like 4-7-8 breathing, which relies on a long exhale rather than a balanced rhythm. If this line of research holds up, the appeal is exactly that the exercise itself is already familiar and free, not some newly discovered technique.

Our Breathe page has this same roughly-six-breaths-a-minute pace built in as the "Coherent" pattern, with a visual pacer to follow instead of counting in your head, if you'd like to try the exercise the study actually used.

Frequently Asked Questions

What exact breathing pattern did the study use? +
Nothing exotic, just paced breathing at roughly five seconds in and five seconds out, about six breaths a minute. Participants followed a visual pacer on a laptop screen rather than counting themselves. That pace is close to what's sometimes called "resonance" or "coherent" breathing.
How is amyloid-beta related to Alzheimer's? +
Amyloid-beta 40 and 42 are peptides that, over time, can clump together into the plaques found in the brains of people with Alzheimer's. Higher levels circulating in blood are associated with greater future risk in healthy adults, though having elevated levels isn't the same as having the disease.
Did the study show fewer people developed Alzheimer's? +
No. Over four weeks, that would be impossible to measure anyway, Alzheimer's develops over decades. What the study measured was a blood biomarker change, not a diagnosis or a cognitive outcome. That distinction matters a lot when judging how strong this finding actually is.
Why did the control group do meditation instead of just nothing? +
To isolate what the paced breathing itself was doing. If both groups had improved by the same amount, the effect could've just been general relaxation or the act of doing a daily practice at all. Instead, only the slow-breathing group showed the amyloid-beta reduction, which strengthens the case that the breathing pace specifically mattered.
Has this study been repeated elsewhere? +
Not yet, as far as the published research shows. A single study, even a well-designed one, is a starting point rather than a settled finding. Independent replication in a separate lab is usually what turns a promising result into something more confidently established.
Is this the same as the breathing exercises used for anxiety or sleep? +
The pace is nearly identical to the "Coherent" pattern already used for general calm and heart rate variability. It's a much gentler, slower rhythm than something like 4-7-8 breathing, which leans on a long exhale rather than an even in-and-out pace.

Share

Share this article

Pass it along to someone who sent you a headline about breathing and Alzheimer's.